AHA26: CRISPR gene editing shows promise in Phase Ib hypertriglyceridaemia trial
Early findings highlight the potential of CRISPR gene editing for sustained triglyceride reductions following a single treatment.
Early findings highlight the potential of CRISPR gene editing for sustained triglyceride reductions following a single treatment.